Compounds > birb 796
Page last updated: 2024-09-04

birb 796 and N-(3-cyano-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)-1-naphthalenecarboxamide

birb 796 has been researched along with N-(3-cyano-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)-1-naphthalenecarboxamide in 1 studies

Compound Research Comparison

Studies
(birb 796)		Trials
(birb 796)		Recent Studies (post-2010)
(birb 796)		Studies
(N-(3-cyano-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)-1-naphthalenecarboxamide)		Trials
(N-(3-cyano-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)-1-naphthalenecarboxamide)		Recent Studies (post-2010) (N-(3-cyano-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)-1-naphthalenecarboxamide)
13758016014

Protein Interaction Comparison

ProteinTaxonomybirb 796 (IC50)N-(3-cyano-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)-1-naphthalenecarboxamide (IC50)
Glutamate receptor ionotropic, NMDA 1 Rattus norvegicus (Norway rat)0.3162
Mitogen-activated protein kinase 8Homo sapiens (human)0.2
Mitogen-activated protein kinase 9Homo sapiens (human)0.2581
Mitogen-activated protein kinase 10Homo sapiens (human)0.1998
Glutamate receptor ionotropic, NMDA 2A Rattus norvegicus (Norway rat)0.3162
Glutamate receptor ionotropic, NMDA 2BRattus norvegicus (Norway rat)0.3162
Glutamate receptor ionotropic, NMDA 2CRattus norvegicus (Norway rat)0.3162
Glutamate receptor ionotropic, NMDA 2DRattus norvegicus (Norway rat)0.3162
Glutamate receptor ionotropic, NMDA 3BRattus norvegicus (Norway rat)0.3162
Glutamate receptor ionotropic, NMDA 3ARattus norvegicus (Norway rat)0.3162

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ1

Other Studies

1 other study(ies) available for birb 796 and N-(3-cyano-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)-1-naphthalenecarboxamide

ArticleYear
Identification of potent Yes1 kinase inhibitors using a library screening approach.
    Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15

    Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship

2013